Why Spectrum Pharmaceuticals Rose 19% Today

In response to reporting fourth-quarter earnings, shares of Spectrum Pharmaceuticals (NASDAQ: SPPI), a beaten-down clinical-stage biotech, rose 19% on Friday.

Spectrum doesn't have any revenue yet, so the financial numbers in its "earnings" report aren't really all that meaningful. However, here are a few of the key figures from the quarter:

Image source: Getty Images.

Continue reading

Source Fool.com